TP53

8 registered clinical trials studyying TP53 — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	The Efficacy and Safety of Glofitamab in Combination With PD-1 Antibody and Lenalidomide in Patients With Rela NCT07240194	The First Affiliated Hospital with Nanjing Medical University	Phase 2
Recruiting	Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagn NCT07008638	Masonic Cancer Center, University of Minnesota	Phase 1 / Phase 2
Recruiting	ALPINE: Maintenance Letrozole/Abemaciclib NCT06366347	Dana-Farber Cancer Institute	Phase 2
Recruiting	AZA Combined With RCHOP in P53-mutated DLBCL. NCT06158399	The First Affiliated Hospital of Xiamen University	Phase 2
Recruiting	MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717	Masonic Cancer Center, University of Minnesota	Phase 2
Not Yet Recruiting	Safety and Efficacy of Aumolertinib Combined With Anlotinib as 1st Line Treatment in Advanced Lung Cancer EGFR NCT05778149	Tianjin Medical University Cancer Institute and Hospital	Phase 2
Unknown	Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in T NCT05528354	Zhejiang University	EARLY_Phase 1
Unknown	Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT NCT04123392	Nanfang Hospital, Southern Medical University	Phase 2 / Phase 3